Abstract
Human tumor specific cytotoxic T lymphocytes (CTL) were expanded on formalin-fixed autologous target tumor cells derived from glioblastoma multiforme. Growth response of the CTL restimulated with the fixed target cells was larger than those with live target cells. The results suggest that formalin-fixed tumor cells will be stable sources of tumor antigen for efficient autologous CTL expansion and be useful for adoptive immunotherapy of tumors.
Similar content being viewed by others
References
Crowley NJ, Darrow TL, Quinn-Allen MA and Seigler HF (1991) MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells.Evidence for restriction by a dominant HLA-A allele. J Immunol 146: 1692-1699.
David P, Zemin W, Caroly D, Hongzhen H, David M, Guimin G, Yunsheng W, Theresa W, Jeffrey B, James L and Patritia WF (1996) Regulation ofCTLA-4 expression during T cell activation. J Immunol 156: 4154-4159.
Hay RJ, Park JG and Gazar A(Edited) (1994) Atlas of human tumor cell lines. Academic Press, Inc., CA, USA.
Holden CA, Spaull J, Williams R, Spry CJF, Jones RR and Jones EW (1986) The detection of endothelial cell antigens in cutaneous tissue using methacarn and periodate lysine paraformaldehyde fixation. J Immunol Methods 91: 45-52.
Kawai K, Sasaki T, Saijo-Kurita K, Akaza H, Koiso K and Ohno T (1992) Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determinded by lactate-dehydrogenaserelease assay. Cancer Immunol Immunother 35: 225-229.
Liu SQ, Saijo K, Todoroki T and Ohno T (1995) Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections. Nature Med 1: 267-271.
Liu SQ, Shiraiwa H, Kawai K, Hayashi H, Akaza H, Kim BS, Oki A, Nishida M Kubo T Hashizaki K Saijo K and Ohno T (1996) Tumor-specific autologous cytotoxic T lymphocytes from tissue sections. Nature Med 2: 1283-1283.
Muul LM, Speiess PJ, Drector EP and Rosenberg SA (1987) Identification of specific cytolytic immuno response against autologous tumor in humans bearing malignant melanoma. J Immunol 138: 989-995.
Pollard K and Holgate CS (1987) Surface antigen preservation by PLP and formalin fixation and the effects of tissue processing. J Immunol Methods 96, 145-145.
Schwartz RH (1992) Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065-1068.
Tjoa BA and Kranz DM (1994) Generation of cytotoxic Tlymphocyte to selfpeptide/class I complex: a model for peptide-mediated tumor rejection. Cancer Res 54: 204-208.
Wolfel T, Herr W, Coulie P, Schmitt U, Meyerzum Buschenfelde KH and Knuth A (1993) Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class-I-restricted cytolytic T-lymphocyte (CTL) clones. Int J Cancer 54: 636-644.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Horiuchi, Ki., Tsurushima, H., Soo Kim, B. et al. Expansion of human autologous cytotoxic T lymphocytes on fixed target tumor cells. Cytotechnology 26, 119–124 (1998). https://doi.org/10.1023/A:1007903614475
Issue Date:
DOI: https://doi.org/10.1023/A:1007903614475